223 related articles for article (PubMed ID: 27099955)
1. Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Maguire MG; Ying GS; Jaffe GJ; Toth CA; Daniel E; Grunwald J; Martin DF; Hagstrom SA;
JAMA Ophthalmol; 2016 Jun; 134(6):674-81. PubMed ID: 27099955
[TBL] [Abstract][Full Text] [Related]
2. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).
Hagstrom SA; Ying GS; Pauer GJT; Sturgill-Short GM; Huang J; Callanan DG; Kim IK; Klein ML; Maguire MG; Martin DF;
Ophthalmology; 2013 Mar; 120(3):593-599. PubMed ID: 23337555
[TBL] [Abstract][Full Text] [Related]
4. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans.
Contreras AV; Zenteno JC; Fernández-López JC; Rodríguez-Corona U; Falfán-Valencia R; Sebastian L; Morales F; Ochoa-Contreras D; Carnevale A; Silva-Zolezzi I
Mol Vis; 2014; 20():105-16. PubMed ID: 24453474
[TBL] [Abstract][Full Text] [Related]
5. Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population.
Liu X; Zhao P; Tang S; Lu F; Hu J; Lei C; Yang X; Lin Y; Ma S; Yang J; Zhang D; Shi Y; Li T; Chen Y; Fan Y; Yang Z
Retina; 2010 Sep; 30(8):1177-84. PubMed ID: 20523265
[TBL] [Abstract][Full Text] [Related]
6. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
[TBL] [Abstract][Full Text] [Related]
7. Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.
Maguire MG; Daniel E; Shah AR; Grunwald JE; Hagstrom SA; Avery RL; Huang J; Martin RW; Roth DB; Castellarin AA; Bakri SJ; Fine SL; Martin DF;
Ophthalmology; 2013 Oct; 120(10):2035-41. PubMed ID: 23706946
[TBL] [Abstract][Full Text] [Related]
8. Investigation of genetic base in the treatment of age-related macular degeneration.
Gourgouli K; Gourgouli I; Tsaousis G; Spai S; Niskopoulou M; Efthimiopoulos S; Lamnissou K
Int Ophthalmol; 2020 Apr; 40(4):985-997. PubMed ID: 31916060
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY
Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345
[TBL] [Abstract][Full Text] [Related]
10. Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration.
Cobos E; Recalde S; Anter J; Hernandez-Sanchez M; Barreales C; Olavarrieta L; Valverde A; Suarez-Figueroa M; Cruz F; Abraldes M; Pérez-Pérez J; Fernández-Robredo P; Arias L; García-Layana A
Acta Ophthalmol; 2018 Mar; 96(2):e201-e212. PubMed ID: 28926193
[TBL] [Abstract][Full Text] [Related]
11. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype.
Loane E; Nolan JM; McKay GJ; Beatty S
Exp Eye Res; 2011 Nov; 93(5):592-8. PubMed ID: 21816153
[TBL] [Abstract][Full Text] [Related]
12. Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration.
Yoneyama S; Sakurada Y; Mabuchi F; Imasawa M; Sugiyama A; Kubota T; Iijima H
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1435-41. PubMed ID: 24595987
[TBL] [Abstract][Full Text] [Related]
13. Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.
Lima LH; Schubert C; Ferrara DC; Merriam JE; Imamura Y; Freund KB; Spaide RF; Yannuzzi LA; Allikmets R
Ophthalmology; 2010 Aug; 117(8):1567-70. PubMed ID: 20378180
[TBL] [Abstract][Full Text] [Related]
14. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
15. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.
Smailhodzic D; Muether PS; Chen J; Kwestro A; Zhang AY; Omar A; Van de Ven JP; Keunen JE; Kirchhof B; Hoyng CB; Klevering BJ; Koenekoop RK; Fauser S; den Hollander AI
Ophthalmology; 2012 Nov; 119(11):2304-11. PubMed ID: 22840423
[TBL] [Abstract][Full Text] [Related]
16. An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population.
Matušková V; Zeman T; Ewerlingová L; Hlinomazová Z; Souček J; Vlková E; Goswami N; Balcar VJ; Šerý O
Acta Ophthalmol; 2020 Sep; 98(6):e691-e699. PubMed ID: 31970928
[TBL] [Abstract][Full Text] [Related]
17. GENETICS OF LARGE PIGMENT EPITHELIAL DETACHMENTS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Mouallem-Beziere A; Blanco-Garavito R; Richard F; Miere A; Jung C; Rozet JM; Souied EH
Retina; 2020 Apr; 40(4):663-671. PubMed ID: 30681643
[TBL] [Abstract][Full Text] [Related]
18. Association of polymorphisms in C2, CFB and C3 with exudative age-related macular degeneration in a Korean population.
Kim SJ; Lee SJ; Kim NR; Chin HS
Exp Eye Res; 2012 Mar; 96(1):42-7. PubMed ID: 22273503
[TBL] [Abstract][Full Text] [Related]
19. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
Abedi F; Wickremasinghe S; Richardson AJ; Islam AF; Guymer RH; Baird PN
Ophthalmology; 2013 Aug; 120(8):1641-8. PubMed ID: 23582991
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration.
Piermarocchi S; Miotto S; Colavito D; Leon A; Segato T
Acta Ophthalmol; 2015 Sep; 93(6):e451-7. PubMed ID: 25402348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
